Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas | MicrobiomeTrials
Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-05-26Est. Completion: 2031-11-04
Enrollment target: 24 participants
Locations
City of Hope Medical Center, Duarte, California, United States
Other microbiome trials you might be interested in